Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study ...

Treatment with high-dose vitamin D reduced disease activity in people with clinically isolated syndrome in a Phase 3 trial.

维生素D缺乏被认为是MS的危险因素之一，但关于维生素D补充的益处仍存在争议。2025年3月10日，发表于JAMA的一项研究发现：每2周口服100,000 IU胆钙化醇显著减少了CIS和早期复发缓解型MS患者的疾病活动性，为维生素D在MS治疗中的潜在作用提供了新的证据， ...

Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...

Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in doses of 100,000 IU every two weeks significantly reduced disease activity ...

Researchers from institutions across France have uncovered solid clinical evidence that supplements of vitamin D could be an ...

A new study from researchers in France has found that taking high doses of vitamin D every two weeks may help reduce disease ...

Walk MS is two weeks away, and more than 1,500 people in the area are hard at work fundraising and building their teams.

Paris: A French study has revealed that taking vitamin D3 (cholecalciferol) orally at a dose of 100,000 international units ...

Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduced disease activity in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS ...